Dr. Roberto Chiesa leads the Laboratory of Prion Neurobiology at the Mario Negri Institute for Pharmacological Research in Milan, Italy, where his research focuses on the molecular mechanisms underlying genetic and acquired prion diseases. His work combines cellular and animal models with translational approaches aimed at identifying new therapeutic strategies and improving early diagnosis. He is also actively involved in international collaborative projects focused on preventive treatments and biomarkers for individuals carrying pathogenic PRNP mutations.

Beyond his scientific work, Dr. Chiesa is strongly committed to supporting patients and families affected by prion diseases. He values close collaboration among researchers, clinicians, and advocacy organizations to help accelerate progress toward effective therapies.